EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High accuracy stool biomarkers of pre-cancerous colorectal cancer identified using a 2000-plex immunoproteomic screen

Kamala Vanarsa, Jessica Castillo, Hao Li, Kala T Pham, Maria Akter, Sravya Gude, Kyung Hyun Lee, Claudia Pedroza, Robert Bresalier, Nicholas Chia, Chandra Mohan

Molecular & Cellular Proteomics · 2025

DOI: 10.1016/j.mcpro.2025.101079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2025. Verfasst von Kamala Vanarsa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department Biomedical Engineering, University of Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, Feces, Proteomics. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the morbidity and mortality associated with colorectal cancer (CRC), novel biomarkers are clearly warranted, especially for early detection. An antibody-based screen of 2000 proteins was utilized to identify stool proteins that were elevated in patients with CRC, compared with healthy controls (HCs). Thirty-seven lead candidates were selected for ELISA validation in three independent cohorts comprised of CRC patients, advanced adenoma patients, and HCs, drawn from two different ethnicities. Of the 2000 proteins interrogated, 116 were differentially expressed in CRC stool, with 45 being elevated at twofold or higher; 37 of these proteins were selected for ELISA validation in three independent patient cohorts. Stool matrix metalloproteinase (MMP)-8, MMP-9, hemoglobin, Peptidoglycan Recognition Protein-S (PGRP-S), haptoglobin, and fibrinogen emerged as being most discriminatory for distinguishing CRC from HCs (area under the curve, 0.91-0.95), across cohorts and ethnicities, with several of these being significantly higher in more advanced stages of CRC. Stool fibrinogen, MMP-9, hemoglobin, MMP-8, and PGRP-S were the top 5 stool proteins with the highest accuracy for distinguishing advanced adenoma from HC, with stool fibrinogen topping the list with a receiver operating characteristic area under the curve value of 0.86. Functional pathway analysis revealed a significant over-representation of pathways related to antioxidant activity, integrin/receptor binding, cytokines, blood coagulation, and lipoprotein biosynthesis in patients with CRC compared with HC. Nuclear factor IC and IKZF2 were identified as key regulators of the molecular cascades over-represented in CRC. Stool fibrinogen, MMP-8, MMP-9, PGRP-S, haptoglobin, and myeloperoxidase emerge as promising biomarkers for distinguishing CRC/advanced adenomas/healthy stools, meeting or outperforming current yardsticks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsBiomarkers, TumorFecesProteomicsPrecancerous ConditionsHumansMaleFemaleMiddle AgedAgedCase-Control StudiesEnzyme-Linked Immunosorbent AssayAdenomaAdult

Stichwörter der Autor:innen

adenomabiomarkercolorectal cancerproteomicsstool

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department Biomedical Engineering, University of Houston, Houston, Texas, USA.
  • Department Biomedical Engineering, University of Houston, Houston, Texas, USA; Department of General Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Biology and Biochemistry, University of Houston, Houston, Texas, USA.
  • Center for Clinical Research and Evidence-based Medicine, McGovern Medical School, UT Health Science Center at Houston, Houston, Texas, USA.
  • Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Surgical Research, Mayo Clinic, Rochester, Minnesota, USA.

Förderung

  • National Institutes of Health

Zitieren

APA

Vanarsa, K., Castillo, J., Li, H., Pham, K. T., Akter, M., Gude, S., Lee, K. H., Pedroza, C., Bresalier, R., Chia, N., & Mohan, C. (2025). High accuracy stool biomarkers of pre-cancerous colorectal cancer identified using a 2000-plex immunoproteomic screen. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2025.101079

Vancouver

Vanarsa K, Castillo J, Li H, Pham KT, Akter M, Gude S, et al. High accuracy stool biomarkers of pre-cancerous colorectal cancer identified using a 2000-plex immunoproteomic screen. Molecular & Cellular Proteomics. 2025. doi:10.1016/j.mcpro.2025.101079

BibTeX
@article{Vanarsa2025,
  author = {Vanarsa, Kamala and Castillo, Jessica and Li, Hao and Pham, Kala T and Akter, Maria and Gude, Sravya and Lee, Kyung Hyun and Pedroza, Claudia and Bresalier, Robert and Chia, Nicholas and Mohan, Chandra},
  title = {High accuracy stool biomarkers of pre-cancerous colorectal cancer identified using a 2000-plex immunoproteomic screen},
  journal = {Molecular & Cellular Proteomics},
  year = {2025},
  doi = {10.1016/j.mcpro.2025.101079}
}
Kostenlos starten →